U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Drug Development Tool (DDT) Qualification Programs
  5. Clinical Outcome Assessment (COA) Qualification Program
  6. DDT COA #000140: PROMIS Itch Questionnaire – Children Symptom (PIQ-C-Symptom)
  1. Clinical Outcome Assessment (COA) Qualification Program

DDT COA #000140: PROMIS Itch Questionnaire – Children Symptom (PIQ-C-Symptom)

Clinical Outcome Assessments (COA) Qualification Submissions
Office of Immunology and Inflammation (OII)
Division of Dermatology and Dentistry (DDD)

DDT COA Number
DDT COA #000140

Instrument Name
PROMIS Itch Questionnaire – Children Symptom (PIQ-C Symptom)

Disease/Condition
Itch

Concept of Interest
Itch symptoms in children

Context of Use
PRO to be completed by children between ages 8-17 years
ObsRO to be completed by parents of children ages 5-17 years

COA Type
PRO and ObsRO

Qualification Stage
Letter of Intent-Not Accepted

Requestor(s)
Northwestern University

Contact(s)
Amy Paller
Jin-Shei Lai

Date Accepted into CDER’s COA Qualification Program
N/A

Submission and Regulatory Correspondence History

Qualification Submission Date FDA Submission Decision & Recommendations Date
Letter of Intent 01/12/2021 FDA Response (Not Accepted) 3/26/21

 

Back to Top